$GLUE Cashflow Statement | Understand Stock

$GLUE

$10.66 +$0.18 (1.72%) Close

$GLUE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation expense
Depreciation
Noncash lease expense
Net accretion of discounts/premiums on marketable securities
Changes in fair value of preferred stock tranche obligations
Loss on sale of marketable securities
Gain on disposal of property and equipment

Changes in operating assets and liabilities
Collaboration receivable
Other receivables
Prepaid expenses and other assets
Accounts payable
Accrued expenses and other current liabilities
Defined benefit plan liability
Right-of-use assets and operating lease liabilities
Deferred revenue
Net cash (used in) provided by operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from sale of property and equipment
Purchases of marketable securities
Proceeds from sale of marketable securities
Proceeds from maturities of marketable securities
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of convertible preferred stock
Payment of convertible preferred stock issuance costs
Proceeds from initial public offering, net of underwriting discount of $17,895
Proceeds from sale of common stock pursuant to the at-the-market sales agreement, net of underwriter's discount
At The Market Offering
Total proceeds from sale of common stock pursuant to the at-the-market sales agreement, net of underwriter's discount
Payment of initial public offering issuance costs
Payment of common stock issuance costs
Proceeds from underwritten public offering, net of underwriter's discount of $3,000
Proceeds from issuance of pre-funded warrants
Payment of common stock and pre-funded warrant issuance costs
Payment of pre-funded warrant issuance costs
Proceeds from exercise of employee stock options
Proceeds from employee stock purchase plan
Net cash provided by financing activities

Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of period
Cash, cash equivalents and restricted cash - end of period
Supplemental disclosure of noncash items
Conversion of convertible preferred stock into common stock
Settlement of preferred stock tranche obligation
Reduction of right-of-use assets for lease incentives receivable
Purchases of property and equipment in accounts payable and accrued expenses

Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents
Restricted cash

Comments